Wells Fargo’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.41M Sell
96,369
-74,449
-44% -$3.03M ﹤0.01% 2884
2025
Q4
$6.94M Sell
170,818
-13,016
-7% -$566K ﹤0.01% 2365
2025
Q3
$8.65M Sell
183,834
-40,413
-18% -$2.1M ﹤0.01% 2116
2025
Q2
$11.7M Sell
224,247
-89,210
-28% -$4.9M ﹤0.01% 1791
2025
Q1
$18.9M Sell
313,457
-66,430
-17% -$4.28M ﹤0.01% 1378
2024
Q4
$26M Sell
379,887
-33,918
-8% -$2.36M 0.01% 1185
2024
Q3
$29.8M Sell
413,805
-11,095
-3% -$783K 0.01% 1056
2024
Q2
$29.5M Sell
424,900
-79,815
-16% -$5.82M 0.01% 1003
2024
Q1
$40.4M Sell
504,715
-100,949
-17% -$9M 0.01% 851
2023
Q4
$66.3M Sell
605,664
-52,862
-8% -$5.47M 0.02% 624
2023
Q3
$66.4M Buy
658,526
+28,885
+5% +$3.32M 0.02% 572
2023
Q2
$85.6M Buy
629,641
+9,724
+2% +$1.19M 0.02% 504
2023
Q1
$64.4M Buy
619,917
+36,865
+6% +$3.57M 0.02% 597
2022
Q4
$51.7M Sell
583,052
-4,386
-0.7% -$364K 0.02% 654
2022
Q3
$47.1M Buy
587,438
+31,476
+6% +$2.97M 0.02% 670
2022
Q2
$53.2M Buy
555,962
+162,140
+41% +$19.5M 0.02% 649
2022
Q1
$58.5M Buy
393,822
+28,012
+8% +$3.91M 0.02% 695
2021
Q4
$51.9M Sell
365,810
-24,296
-6% -$3.44M 0.01% 764
2021
Q3
$51M Buy
390,106
+91,990
+31% +$12M 0.01% 1043
2021
Q2
$41M Sell
298,116
-28,643
-9% -$3.92M 0.01% 1198
2021
Q1
$42.7M Sell
326,759
-34,291
-9% -$4.13M 0.01% 1133
2020
Q4
$40.4M Buy
361,050
+35,122
+11% +$3.33M 0.01% 1106
2020
Q3
$25.6M Buy
325,928
+76,540
+31% +$6.24M 0.01% 1257
2020
Q2
$18M Sell
249,388
-98,035
-28% -$6.82M 0.01% 1437
2020
Q1
$19.9M Buy
347,423
+96,081
+38% +$8.86M 0.01% 1238
2019
Q4
$28.1M Sell
251,342
-22,723
-8% -$2.42M 0.01% 1261
2019
Q3
$26.4M Sell
274,065
-8,340
-3% -$783K 0.01% 1262
2019
Q2
$24.2M Buy
282,405
+40,600
+17% +$3.34M 0.01% 1355
2019
Q1
$20.1M Buy
241,805
+181,230
+299% +$13.2M 0.01% 1441
2018
Q4
$3.89M Buy
60,575
+5,028
+9% +$344K ﹤0.01% 2685
2018
Q3
$4.4M Buy
55,547
+399
+0.7% +$30.9K ﹤0.01% 2742
2018
Q2
$4.04M Buy
55,148
+2,965
+6% +$202K ﹤0.01% 2881
2018
Q1
$3.31M Buy
52,183
+3,683
+8% +$220K ﹤0.01% 2957
2017
Q4
$2.47M Buy
48,500
+8,276
+21% +$431K ﹤0.01% 3198
2017
Q3
$2.11M Buy
40,224
+10,394
+35% +$522K ﹤0.01% 3272
2017
Q2
$1.52M Buy
29,830
+2,404
+9% +$119K ﹤0.01% 3411
2017
Q1
$1.22M Sell
27,426
-379
-1% -$16.3K ﹤0.01% 3592
2016
Q4
$1.23M Buy
27,805
+1,977
+8% +$84K ﹤0.01% 3542
2016
Q3
$1.03M Sell
25,828
-398
-2% -$16.9K ﹤0.01% 3472
2016
Q2
$1.25M Buy
26,226
+610
+2% +$25.8K ﹤0.01% 3321
2016
Q1
$1.07M Buy
25,616
+5,171
+25% +$203K ﹤0.01% 3370
2015
Q4
$901K Buy
20,445
+6,566
+47% +$285K ﹤0.01% 3544
2015
Q3
$663K Sell
13,879
-3,448
-20% -$189K ﹤0.01% 3769
2015
Q2
$1.01M Buy
17,327
+5,565
+47% +$300K ﹤0.01% 3591
2015
Q1
$594K Buy
11,762
+1,140
+11% +$55.9K ﹤0.01% 3842
2014
Q4
$478K Sell
10,622
-5,436
-34% -$228K ﹤0.01% 3973
2014
Q3
$591K Sell
16,058
-1,543
-9% -$61.2K ﹤0.01% 3795
2014
Q2
$778K Buy
17,601
+1,942
+12% +$88.1K ﹤0.01% 3677
2014
Q1
$680K Sell
15,659
-455
-3% -$20.3K ﹤0.01% 3727
2013
Q4
$684K Buy
16,114
+433
+3% +$16.5K ﹤0.01% 3641
2013
Q3
$533K Buy
15,681
+1,528
+11% +$49.9K ﹤0.01% 3729
2013
Q2
$442K Buy
+14,153
New +$459K ﹤0.01% 3759

Other funds holding CNMD

Wells Fargo's CNMD Position: Q1 2026 in Review

Wells Fargo reduced its CONMED (CNMD) stake by 44% in Q1 2026, selling an estimated $3.03M and leaving 96,369 shares worth $3.41M. The position accounts for ﹤0.01% of the portfolio, ranked #2884.

Wells Fargo first reported a position in CNMD in Q2 2013 and has held it in 52 quarters since. The position peaked at $85.6M in Q2 2023. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • Wells Fargo held 96,369 shares of CONMED worth $3.41M as of Q1 2026.
  • Wells Fargo sold 74,449 CONMED shares in Q1 2026, an estimated $3.03M.
  • CONMED made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #2884 holding.
  • Wells Fargo first reported a position in CONMED in Q2 2013 and has held it in 52 quarters since.
  • Wells Fargo's CONMED position peaked at $85.6M in Q2 2023.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.